| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |